| Literature DB >> 29104243 |
Yan-Xiu Chen1,2, Meng-Yang Xu3, Hou-Jin Li4, Kun-Jiao Zeng5, Wen-Zhe Ma6, Guo-Bao Tian7, Jun Xu8, De-Po Yang9,10, Wen-Jian Lan11,12.
Abstract
By adding l-tryptophan and l-phenylalanine to GPY medium, twenty-eight compounds, including amides, polyketides, a sesquiterpenoid, a diterpenoid, a meroterpenoid, diketopiperazines, β-carbolines, fumiquinazolines, and indole alkaloids, were discovered from the marine-derived fungus Dichotomomyces cejpii F31-1, demonstrating the tremendous biosynthetic potential of this fungal strain. Among these compounds, four amides dichotomocejs A-D (1-4), one polyketide dichocetide A (5), and two diketopiperazines dichocerazines A-B (15 and 16) are new. The structures of these new compounds were determined by interpreting detailed spectroscopic data as well as calculating optical rotation values and ECD spectra. Obviously, Dichotomomyces cejpii can effectively use an amino acid-directed strategy to enhance the production of nitrogen-containing compounds. Dichotomocej A (1) displayed moderate cytotoxicity against the human rhabdomyosarcoma cell line RD with an IC50 value of 39.1 µM, and pityriacitrin (22) showed moderate cytotoxicity against the human colon carcinoma cell line HCT116 with an IC50 value of 35.1 µM.Entities:
Keywords: Dichotomomyces cejpii; amino acid-directed strategy; bioactivity; diverse secondary metabolites; nitrogen-containing compounds
Mesh:
Substances:
Year: 2017 PMID: 29104243 PMCID: PMC5706029 DOI: 10.3390/md15110339
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Chemical structures of compounds 1–28.
13C NMR data for compounds 1–5 and 15–16 (100 MHz, CDCl3).
| No. | 1 | 2 | 3 | 4 | 5 | 15 | 16 |
|---|---|---|---|---|---|---|---|
| 1 | 170.4, C | 170.3, C | 169.1, C | 168.9, C | 75.8, CH | 156.7, C | 165.8, C |
| 2 | 127.3, C | 127.2, C | 127.3, C | 127.3, C | 31.0, CH | N | N |
| 3 | 134.6, CH | 134.6, CH | 134.5, CH | 134.1, CH | 36.3, CH2 | 66.8, CH | 71.7, C |
| 4 | 127.2, CH | 127.1, CH | 127.2, CH | 127.1, CH | 133.4, C | 161.8, C | 164.4, C |
| 5 | 136.7, CH | 136.7, CH | 136.6, CH | 136.2, CH | 130.5, CH | N | N |
| 6 | 18.9, CH3 | 19.0, CH3 | 18.9, CH3 | 18.9, CH3 | 134.6, C | 129.2, C | 70.9, CH |
| 7 | 13.0, CH3 | 13.0, CH3 | 12.9, CH3 | 12.6, CH3 | 134.4, C | 116.5, CH | 75.2, CH |
| 8 | 67.1, CH2 | 66.4, CH2 | 174.0, C | 66.6, CH2 | 130.6, CH | 128.3, CH | 190.9, C |
| 9 | 50.7, CH | 50.5, CH | 51.1, CH | 47.0, CH | 138.6, C | 125.7, CH | 127.2, CH |
| 10 | 40.5, CH2 | 38.3, CH2 | 42.1, CH2 | 40.8, CH2 | 37.8, CH | 122.8, CH | 148.4, CH |
| 11 | 25.3, CH | 31.5, CH | 25.1, CH | 24.9, CH | 17.2, CH3 | 134.9, C | 76.4, C |
| 12 | 23.2, CH3 | 29.1, CH2 | 22.9, CH3 | 23.0, CH3 | 18.2, CH3 | 115.1, CH | 51.1, CH2 |
| 13 | 22.4, CH3 | 11.2, CH3 | 22.3, CH3 | 22.4, CH3 | 19.3, CH3 | 127.9, C | 69.4, C |
| 14 | NH | 19.6, CH3 | 52.4, CH3 | 172.3, C | 43.0, CH2 | 32.2, CH3 | 15.3, CH3 |
| 15 | NH | NH | NH | 68.1, CH | 12.7, CH3 | 29.6, CH3 | |
| 16 | 31.5, CH2 | 23.2, CH3 | 64.0, CH2 | ||||
| 17 | 108.4, C | 13.7, CH3 | |||||
| 18 | 123.3, CH | 170.1, C | |||||
| 19 | NH | 20.7, CH3 | |||||
| 20 | 136.3, C | ||||||
| 21 | 111.5, CH | ||||||
| 22 | 122.3, CH | ||||||
| 23 | 119.8, CH | ||||||
| 24 | 118.8, CH | ||||||
| 25 | 127.4, C |
1H NMR data for compounds 1–4 (400 MHz, CDCl3).
| No. | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| 3 | 6.88 (d, 11.2) | 6.88 (d, 11.2) | 6.88 (d, 10.8) | 6.76 (d, 11.2) |
| 4 | 6.33 (ddq, 13.2, 11.2, 1.6) | 6.31 (ddq, 14.8, 11.2, 1.6) | 6.32 (ddq, 15.2, 10.8, 1.6) | 6.27 (ddq, 14.8, 11.2, 1.6) |
| 5 | 6.04 (dq, 13.2, 6.8) | 6.02 (dq, 14.8, 6.8) | 6.03 (dq, 15.2, 6.8) | 5.97 (dq, 14.8, 6.8) |
| 6 | 1.86 (d, 6.4) | 1.85 (d, 6.8) | 1.85 (d, 6.4) | 1.85 (d, 6.8) |
| 7 | 1.94 (s) | 1.93 (s) | 1.95 (s) | 1.72 (s) |
| 8 | 3.57 (dd, 10.8, 6.0); | 3.55 (dd, 10.8, 6.0); | 4.09 (dd, 11.2, 4.0); | |
| 9 | 4.12 (m) | 4.11 (m) | 4.71 (td, 8.4, 5.2) | 4.33 (m) |
| 10 | 1.41 (dt, 8.4, 6.0) | 1.31 (dd, 13.2, 6.0); | 1.58 (m); 1.70 (m) | 1.24 (m) |
| 11 | 1.66 (m) | 1.44 (m) | 1.67 (m) | 1.52 (m) |
| 12 | 0.95 (d, 6.8) | 1.14 (t, 6.8); 1.39 (m) | 0.95 (d, 6.4) | 0.85 (d, 6.4) |
| 13 | 0.94 (d, 6.8) | 0.86 (t, 6.8) | 0.95 (d, 6.4) | 0.85 (d, 6.4) |
| 14 | 5.77 (brd, 6.4) | 0.92 (d, 6.4) | 3.74 (s) | |
| 15 | 5.87 (brd, 7.2) | 6.10 (d, 8.0) | 5.54 (d, 8,8) | |
| 16 | 3.79 (s) | |||
| 18 | 7.11 (s) | |||
| 19 | 8.38 (brs) | |||
| 21 | 7.34 (d, 8.0) | |||
| 22 | 7.18 (dd, 8.0, 8.0) | |||
| 23 | 7.11 (dd, 8.0, 8.0) | |||
| 24 | 7.61 (d, 8.0) |
Figure 2The 1H-1H COSY (bold line) and key HMBC correlations (arrows) of compounds 1–5 and 15–16.
1H NMR data for compounds 5 and 15–16 (400MHz, CDCl3).
| No. | 5 | 15 | 16 |
|---|---|---|---|
| 1 | 3.71 (dd, 9.2, 4.8) | ||
| 2 | 2.07, m | ||
| 3 | 2.41 (dd, 16.8, 9.6); 2.92 (dd, 16.8, 6.4) | 5.04 (s) | |
| 5 | 6.87 (s) | ||
| 6 | 5.14 (d, 11.2) | ||
| 7 | 8.42 (d, 8.0) | 5.89 (d, 11.2) | |
| 8 | 6.94 (s) | 7.53 (t, 8.0) | |
| 9 | 7.40 (t, 8.0) | 6.10 (d, 10.4) | |
| 10 | 3.03 (m) | 7.70 (d, 8.0) | 6.92 (d, 10.4) |
| 11 | 1.25 (d, 7.2) | ||
| 12 | 1.11 (d, 6.4) | 7.46 (s) | 2.80 (d, 16.0); 3.42 (d, 16.0) |
| 13 | 2.26 (s) | ||
| 14 | 2.67 (dd, 13.6, 8.4); 2.76 (dd, 13.6, 4.4) | 3.24 (s) | 2.23 (s) |
| 15 | 4.00, m | 2.05 (s) | 3.10 (s) |
| 16 | 1.27 (d, 6.4) | 3.85 (d, 12.0); 4.31 (d, 12.0) | |
| 17 | 2.19 (s) | ||
| 19 | 2.17 (s) |
Figure 3Comparison of the experimental and calculated ECD spectra of 5 and 16.